Paindore

CEO –Dorit Daniel- B.Sc Chemical Eng. Former CEO and founder of medical device and drug delivery company ( TheraCoat Ltd) developing invoative slow release administrating formulation and device for chemotherapy treatment for blodder cancer; Dorit is a former General Manager of CorAssist Cardiovascular Ltd., a start up company in the Cardiac Medical Device area. Dorit has an extensive experience in formulation development and management in the pharmaceutical field and others. She was previously a project manager at Transpharma Medical and developed hydrophilic transdermal patch. Dorit owns a B.Sc. degree in Chemical Engineering from the Technion, Haifa.

Founding Team

Prof. David Yarnitski, MD: head of the Department of Neurology in the Rambam Health

Care Campus, head of the Clinical Neurophysiology lab and immediate past head of the

Neurology section in the Technion Faculty of Medicine, Haifa. He has graduated from the

Technioin Medical School, and trained in Rambam, Oregon Health Sciences University

and Beth Israel - Harvard. His main research interest is sensory function, specifically pain

mechanisms and therapy, and he is also involved in research on cerebrovascular diseases

and the autonomic nervous system. David Yarnisty was one of the founders of BrainsGate

Ltd., and is currently consulting to several biotechnological companies.

Yoram Sela, Ph.D. Dr. Yoram Sela Lycored V.P Pharmaceutical, previously the President

of Israel Controlled Release Society. The Co-Founder and R&D Manager of Karma Pharm

Ltd. Former Manager of the Drug Delivery Systems department at Teva Pharmaceutical

Ltd.

Itschak Lamensdorf, Ph.D. Dr. Itschak Lamensdorf the former CEO of PharmaSense

Ltd., a biotechnological company that developed drugs for the treatment of CNS disorders.

Dr. Lamensdorf holds a Ph.D. in pharmacology and an M.Sc. in clinical pharmacy. He has

held postdoctoral positions at the National Institute of Neurological Disorders and Stroke

of the National Institute of Health (NIH) Bethesda, Maryland and at the Molecular

Genetics Department of Israel’s Weizmann Institute of Science.

Alon Shalev, M.Sc: Combines a 15-years broad technological experience with R&D and

managemental skills in the Hi-Tech sector and in emerging Medical Device companies.

Alon lead BrainsGate from its inception phase, into its European clinical trials with a

highly innovative technological and clinical platform. Alon than lead Nicast from a 10-

years phase of exploratory work in different fields into its First-In-Man clinical trials and

the CE approval process. Received a B.Sc. in Electrical Engineering M.Sc. Cum Laude in

Physical Electronics from the Tel-Aviv University;